Light and Electron Microscopic investigation of Semelil (ANGIPARSTM) on therapeutic process after chronic myocardial infarction in rabbit

  • سال انتشار: 1395
  • محل انتشار: سومین کنفرانس بین المللی پژوهش در مهندسی، علوم و تکنولوژی
  • کد COI اختصاصی: RSTCONF03_195
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 696
دانلود فایل این مقاله

نویسندگان

Abouzar Talakoub

Department of Basic sciences, Ferdowsi University of Mashhad, Iran

Abolghasem Nabipour

Department of Basic sciences, Ferdowsi University of Mashhad, Iran

Mohsen Maleki

Department of Pathobiology, Ferdowsi University of Mashhad, Iran

Majid Asadi-Shekaari

Department of Anatomy, Faculty of Medicine, Medical University of Medical Sciences, Kerman, Iran

چکیده

One of the main therapeutic intentions of modern cardiology is to contrive strategies aimed atdecreasing myocardial necrosis and improving cardiac healing following myocardialinfarction (MI). This investigation was contrived to study the protective effects of Semelil(ANGIPARS™), a native herbal medicine, on MI in the rabbit model. Twenty-five NewZealand white rabbits were utilized in this investigation. Rabbits were allocated to equalgroups: control plus vehicle; sham; sham plus vehicle; ischemia plus vehicle; Semelil 10mg/kg, respectively. MI was created by the complete closure of Left Anterior DescendingCoronary Artery (LADC). The animals were treated with Semelil 10 mg/kg daily for 14 days.Electrophysiological, Biochemical, histological and ultrastructural studies were used fordetecting protective effects of Semelil. Based on our data, Semelil ameliorated the ECGpattern. Besides, treatment with Semelil improved levels of Creatine Kinase, creatine kinaseisoenzyme and Lactate dehydrogenase comparing to the ischemia group. Morphological datashowed that Semelil could protect cardiomyocytes against myocardial infarction insults. Theresults indicate that Semelil may have protective effects against ischemic damages induced byLAD obstruction in male rabbits due to its anti-inflammatory and antioxidant properties.

کلیدواژه ها

Myocardial infarction, Semelil (ANGIPARS™), Mitochondria, Electron microscopy

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.